Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Item
http://www.wikidata.org/entity/Q39343784
Inorganic nanolayers: structure, preparation, and biomedical applicationsPreparation and controlled-release studies of a protocatechuic acid-magnesium/aluminum-layered double hydroxide nanocomposite.Development of drug delivery systems based on layered hydroxides for nanomedicine.Preparation of Fe₃O₄ magnetic nanoparticles coated with gallic acid for drug delivery.Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications.Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement.Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme.In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides.Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.Preparation and characterization of an anti-inflammatory agent based on a zinc-layered hydroxide-salicylate nanohybrid and its effect on viability of Vero-3 cells.Formulation of venlafaxine for once daily administration using polymeric material hybrids.Controlled release of organic-inorganic nanohybrid:cefadroxil intercalated Zn-Al-layered double hydroxide.
P2860

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Item
http://www.wikidata.org/entity/Q39343784
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@en
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@nl
type
label
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@en
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@nl
prefLabel
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@en
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932
P356
P1433
P1476
Controlled release and angiote ...... ouble hydroxide nanocomposite.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932